References
- Mygind N. Advances in the medical treatment of nasal polyps. Allergy 1999;54:12–16.
- Tuncer U, Soylu L, Aydogan B, Karakus F, Akcali C. The effectiveness of steroid treatment in nasal polyposis. Auris Nasus Larynx 2003;30:263–8.
- Fokkens W, Lund V, Mullol J. EP3OS 2007. European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 2007;45:97–101.
- Holmström M. Clinical performance of fluticasone propionate nasal drops. Allergy 1999;54:21–5.
- Penttilä M, Poulsen P, Hollingworth K, Holmström M. Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 microg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled randomized study in adult patients. Clin Exp Allergy 2000;30:94–102.
- Ehnhage A, Olsson P, Kölbeck KG, Skedinger M, Dahlén B, Ålenius M, et al. Functional endoscopic sinus surgery improved asthma symptoms as well as PEFR and olfaction in patients with nasal polyposis. Allergy 2009;64:762–9.
- Alobid I, Bernal-Sprekelsen M, Mullol J. Chronic rhinosinusitis and nasal polyps: the role of generic and specific questionnaires on assessing its impact on patient's quality of life. Allergy 2008;63:1267–9.
- Alobid I, Benítez P, Bernal-Sprekelsen M, Guilemany JM, Picado C, Mullol J. Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy 2005;60:452–8.
- Olsson P, Ehnhage A, Nordin S, Stjärne P. Quality of life is improved by endoscopic sinus surgery and fluticasone nasal drops in nasal polyposis with asthma. Rhinology 2013; in press.
- Dupuy HJ. Self-representations of general psychological well-being of American adults. Paper presented at American Public Health Association Meeting. Los Angeles: October, 1978.
- McDowell I. 2006. Measuring health: a guide to rating scales and questionnaires. New York: Oxford University Press.
- Nordin S, Brämerson A, Murphy C, Bende M. A Scandinavian adaptation of the Multi-Clinic Smell and Taste Questionnaire: evaluation of questions about olfaction. Acta Otolaryngol 2003;123:536–42.
- Fazio AF. A concurrent validational study of the NCHS General Well-Being Schedule. Vital Health Stat 2 1977;73:1–53.
- Bowling A. 1997. Measuring health: a review of quality of life measurement scales. Philadelphia: Open University Press.
- Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994;94:182–8.
- Bousquet J, Knani J, Dhivert H, Richard A, Chicoye A, Ware JE Jr, et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994;149:371–5.
- Radenne F, Lamblin C, Vandezande LM, Tillie-Leblond I, Darras J, Tonnel AB, et al. Quality of life in nasal polyposis. J Allergy Clin Immunol 1999;104:79–84.
- Hummel T, Nordin S. Olfactory disorders and their consequences for quality of life: a review. Acta Otolaryngol 2005;125:116–21.
- Hedén Blomqvist E, Brämerson A, Stjärne P, Nordin S. Consequences of olfactory loss and adopted coping startegies. Rhinology 2004;42:189–94.